Friday, April 16, 2021

 

7:00 – 8:00 AM

Breakfast Product Theater (Non-Accredited)

8 Weeks: The Shortest Route to a Cure

Richard Manch, MD 

Sponsored by: AbbVie

 

8:00 – 8:10 AM

Welcome/Introduction

In Memoriam of John C. Martin

Zobair Younossi, MD, MPH

​

8:10 – 8:55 AM

Keynote Address

Hepatitis C: The End of the Beginning and Possibly the Beginning of the End 

Harvey Alter, MD, MACP

​

Session I

Marcelo Kugelmas, MD 

​

8:55 – 9:25 AM

Hepatitis C: Elimination Strategies in the US

David Bernstein, MD

​

9:25 – 9:50 AM

Chronic Hepatitis B and D: Emerging Concepts and Treatment

Robert Gish, MD

​

9:50 – 10:10 AM

Panel Discussion/Q&A

Moderator: Marcelo Kugelmas, MD

​

10:10 – 10:25 AM

Break

​

Session II

Zobair Younossi, MD, MPH

​

10:25 – 10:50 AM

State of the Art on Alcoholic Liver Disease

Michael Lucey, MD

 

10:50 – 11:o5 AM

Identifying High Risk NASH Patients Using Noninvasive Techniques

Mazen Noureddin, MD, MHSc

​

11:05 – 11:35 AM

Panel/Case Discussion: Treatments for Weight Loss

Scott Isaacs, MD; Mary Rinella, MD; and Miriam Vos, MD, MSPH

Moderator: Zobair Younossi, MD, MPH

​

11:35 AM-12:00 PM

Emerging Therapies in NASH

Stephen Harrison, MD

​

12:00 – 12:15 PM

Panel Discussion/Q&A

Moderator: Zobair Younossi, MD, MPH

​

12:15 – 12:45 PM

Lunch  

​

Session III

Kimberly Brown, MD

​

12:45 – 1:10 PM

Cholestatic Liver Disease: Current Management & Emerging Therapies

Kris Kowdley, MD 

​

1:10 – 1:35 PM

Appropriate Clinical Decisions in the Treatment of Thrombocytopenia

Robert Brown, MD, MPH

​

1:35 – 2:00 PM

Panel Discussion/Q&A

Moderator: Kimberly Brown, MD

​

2:00 – 2:15 PM

Closing Remarks

Kimberly Brown, MD

​